ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

St. Jude Offers Three Fellowships

May 3, 1985

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

UPCC Wins $26 Million Center Grant From NCI; Massey Center Opens New Outpatient Clinic.

October 20, 2000

Senate Emphasizes Balance In NCI’s Research Programs

September 24, 1993

Study Suggests Surveillance Colonoscopies Overperformed

August 27, 2004

DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board

May 22, 1981